Downregulation of the glucocorticoid-induced leucine zipper (GILZ) promotes vascular inflammation

Atherosclerosis

Volumn 234, Issue 2, 2014, Pages 391-400

  Hahn, Rebecca T ^a   Hoppstädter, Jessica ^a   Hirschfelder, Kerstin ^a   Hachenthal, Nina ^a   Diesel, Britta ^a   Kessler, Sonja M ^a   Huwer, Hanno ^b   Kiemer, Alexandra K ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Völklingen Heart Centre   (Germany)

Author keywords

Atherosclerosis; Laminar shear stress; MRNA stability; NF B; Toll like receptor 2 (TLR2); Tristetraprolin (TTP ZFP36); Vein graft failure

Indexed keywords

GLUCOCORTICOID INDUCED LEUCINE ZIPPER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEIC ACID BINDING PROTEIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCL2 PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TSC22D3 PROTEIN, HUMAN; ZFP36 PROTEIN, HUMAN;

ARTICLE; BYPASS SURGERY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SAPHENOUS VEIN; SHEAR STRESS; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULITIS; CASE CONTROL STUDY; CELL CULTURE; CORONARY ARTERY BYPASS GRAFT; DOWN REGULATION; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MECHANICAL STRESS; METABOLISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME;

CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINE CCL2; CORONARY ARTERY BYPASS; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RNA INTERFERENCE; SAPHENOUS VEIN; SIGNAL TRANSDUCTION; STRESS, MECHANICAL; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TRANSCRIPTION FACTORS; TRANSFECTION; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 84900851404     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.03.028     Document Type: Article

References (50)

1. Karper J.C., de Vries M.R., van den Brand B.T., Hoefer I.E., Fischer J.W., Jukema J.W., et al. Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice. Arterioscler Thromb Vasc Biol 2011, 31:1033-1040.
2. McPhee J.T., Nguyen L.L., Ho K.J., Ozaki C.K., Conte M.S., Belkin M. Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia. JVasc Surg 2013, 57:1481-1488.
3. McKellar G.E., McCarey D.W., Sattar N., McInnes I.B. Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 2009, 6:410-417.
4. Feng Y., Gordts S.C., Chen F., Hu Y., Van C.E., Jacobs F., et al. Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice. Atherosclerosis 2011, 214:271-278.
5. Cunningham K.S., Gotlieb A.I. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 2005, 85:9-23.
6. Davies P.F. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med 2009, 6:16-26.
7. Ayroldi E., Riccardi C. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 2009, 23:3649-3658.
8. Cheng Q., Fan H., Ngo D., Beaulieu E., Leung P., Lo C.Y., et al. GILZ overexpression inhibits endothelial cell adhesive function through regulation of NF-kappaB and MAPK activity. JImmunol 2013, 191:424-433.
9. Hoppstädter J., Diesel B., Eifler L.K., Schmidt T., Brüne B., Kiemer A.K. Glucocorticoid-Induced Leucine Zipper is downregulated in human alveolar macrophages upon Toll-like receptor activation. Eur J Immunol 2012, 42:1-13.
10. Zhang H., Taylor W.R., Joseph G., Caracciolo V., Gonzales D.M., Sidell N., et al. mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells. Arterioscler Thromb Vasc Biol 2013, 33:1212-1220.
11. Huotari N., Hommo T., Taimi V., Nieminen R., Moilanen E., Korhonen R. Regulation of tristetraprolin expression by mitogen-activated protein kinase phosphatase-1. APMIS 2012, 120:988-999.
12. Kiemer A.K., Weber N.C., Furst R., Bildner N., Kulhanek-Heinze S., Vollmar A.M. Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ Res 2002, 90:874-881.
13. Kim H.S., Ullevig S.L., Zamora D., Lee C.F., Asmis R. Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment. Proc Natl Acad Sci U S A 2012, 109:E2803-E2812.
14. Zakkar M., Chaudhury H., Sandvik G., Enesa K., Luong lA., Cuhlmann S., et al. Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. Circ Res 2008, 103:726-732.
15. Imaizumi S., Grijalva V., Priceman S., Wu L., Su F., Farias-Eisner R., et al. Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels. Mol Genet Metab 2010, 101:66-75.
16. Shen J., Chandrasekharan U.M., Ashraf M.Z., Long E., Morton R.E., Liu Y., et al. Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis. Circ Res 2010, 106:902-910.
17. Tybl E., Shi F.D., Kessler S.M., Tierling S., Walter J., Bohle R.M., et al. Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. JHepatol 2011, 54:994-1001.
18. Simon Y., Kessler S.M., Bohle R.M., Haybaeck J., Kiemer A.K. The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62/IGF2BP2-2 as a promoter of NAFLD and HCC?. Gut 2014, 63:861-863.
19. Weber N.C., Blumenthal S.B., Hartung T., Vollmar A.M., Kiemer A.K. ANP inhibits TNF-alpha-induced endothelial MCP-1 expression-involvement of p38 MAPK and MKP-1. JLeukoc Biol 2003, 74:932-941.
20. Diesel B., Ripoche N., Risch R.T., Tierling S., Walter J., Kiemer A.K. Inflammation-induced up-regulation of TLR2 expression in human endothelial cells is independent of differential methylation in the TLR2 promoter CpG island. Innate Immun 2012, 18:112-123.
21. Kiemer A.K., Senaratne R.H., Hoppstädter J., Diesel B., Riley L.W., Tabeta K., et al. Attenuated activation of macrophage TLR9 by DNA from virulent mycobacteria. JInnate Immun 2009, 1:29-45.
22. Frangos J.A., McIntire L.V., Eskin S.G. Shear stress induced stimulation of mammalian cell metabolism. Biotechnol Bioeng 1988, 32:1053-1060.
23. Kessler S.M., Pokorny J., Zimmer V., Laggai S., Lammert F., Bohle R.M., et al. IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling. Am J Physiol Gastrointest Liver Physiol 2013, 304:G328-G336.
24. Kiemer A.K., Vollmar A.M. Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. JBiol Chem 1998, 273:13444-13451.
25. Tiegs G., Küsters S., Künstle G., Hentze H., Kiemer A.K., Wendel A. Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury. JPharmacol Exp Ther 1998, 287:1098-1104.
26. Dünschede F., Tybl E., Kiemer A.K., Dutkowski P., Erbes K., Kircher A., et al. Bcl-2 upregulation after 3-nitropropionic acid preconditioning in warm rat liver ischemia. Shock 2008, 30:699-704.
27. Brook M., Tchen C.R., Santalucia T., McIlrath J., Arthur J.S., Saklatvala J., et al. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol 2006, 26:2408-2418.
28. Kiemer A.K., Weber N.C., Vollmar A.M. Induction of IkappaB: atrial natriuretic peptide as a regulator of the NF-kappaB pathway. Biochem Biophys Res Commun 2002, 295:1068-1076.
29. Berrebi D., Bruscoli S., Cohen N., Foussat A., Migliorati G., Bouchet-Delbos L., et al. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 2003, 101:729-738.
30. Zhang X.H., Lu X., Long X.B., You X.J., Gao Q.X., Cui Y.H., et al. Chronic rhinosinusitis with and without nasal polyps is associated with decreased expression of glucocorticoid-induced leucine zipper. Clin Exp Allergy 2009, 39:647-654.
31. Beaulieu E., Ngo D., Santos L., Yang Y.H., Smith M., Jorgensen C., et al. Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis. Arthritis Rheum 2010, 62:2651-2661.
32. Cannarile L., Cuzzocrea S., Santucci L., Agostini M., Mazzon E., Esposito E., et al. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis. Gastroenterology 2009, 136:530-541.
33. Sima A.V., Stancu C.S., Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res 2009, 335:191-203.
34. Gomez M., Raju S.V., Viswanathan A., Painter R.G., Bonvillain R., Byrne P., et al. Ethanol upregulates glucocorticoid-induced leucine zipper expression and modulates cellular inflammatory responses in lung epithelial cells. JImmunol 2010, 184:5715-5722.
35. McCormick S.M., Eskin S.G., McIntire L.V., Teng C.L., Lu C.M., Russell C.G., et al. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci U S A 2001, 98:8955-8960.
36. Tzima E., Irani-Tehrani M., Kiosses W.B., Dejana E., Schultz D.A., Engelhardt B., et al. Amechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005, 437:426-431.
37. Ji J.Y., Jing H., Diamond S.L. Shear stress causes nuclear localization of endothelial glucocorticoid receptor and expression from the GRE promoter. Circ Res 2003, 92:279-285.
38. Carballo E., Lai W.S., Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998, 281:1001-1005.
39. Lai W.S., Carballo E., Strum J.R., Kennington E.A., Phillips R.S., Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 1999, 19:4311-4323.
40. Stoecklin G., Tenenbaum S.A., Mayo T., Chittur S.V., George A.D., Baroni T.E., et al. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. JBiol Chem 2008, 283:11689-11699.
41. George A.D., Tenenbaum S.A. MicroRNA modulation of RNA-binding protein regulatory elements. RNA Biol 2006, 3:57-59.
42. Delfino D.V., Spinicelli S., Pozzesi N., Pierangeli S., Velardi E., Bruscoli S., et al. Glucocorticoid-induced activation of caspase-8 protects the glucocorticoid-induced protein Gilz from proteasomal degradation and induces its binding to SUMO-1 in murine thymocytes. Cell Death Differ 2011, 18:183-190.
43. Ronkina N., Menon M.B., Schwermann J., Arthur J.S., Legault H., Telliez J.B., et al. Stress induced gene expression: a direct role for MAPKAP kinases in transcriptional activation of immediate early genes. Nucleic Acids Res 2011, 39:2503-2518.
44. Stoecklin G., Stubbs T., Kedersha N., Wax S., Rigby W.F., Blackwell T.K., et al. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J 2004, 23:1313-1324.
45. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
46. Gareus R., Kotsaki E., Xanthoulea S., van dM I., Gijbels M.J., Kardakaris R., et al. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab 2008, 8:372-383.
47. Saito T., Hasegawa Y., Ishigaki Y., Yamada T., Gao J., Imai J., et al. Importance of endothelial NF-kappaB signalling in vascular remodelling and aortic aneurysm formation. Cardiovasc Res 2013, 97:106-114.
48. Ayroldi E., Migliorati G., Bruscoli S., Marchetti C., Zollo O., Cannarile L., et al. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 2001, 98:743-753.
49. Di Marco B., Massetti M., Bruscoli S., Macchiarulo A., Di V.R., Velardi E., et al. Glucocorticoid-induced leucine zipper (GILZ)/NF-kappaB interaction: role of GILZ homo-dimerization and C-terminal domain. Nucleic Acids Res 2007, 35:517-528.
50. Eddleston J., Herschbach J., Wagelie-Steffen A.L., Christiansen S.C., Zuraw B.L. The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. JAllergy Clin Immunol 2007, 119:115-122.